Thromboxane A2 mediates the stimulation of inositol 1,4,5- trisphosphate production and intracellular calcium mobilization by bradykinin in neonatal rat ventricular cardiomyocytes

Hypertension

Volumn 28, Issue 3, 1996, Pages 444-449

  Nakamura, Fumiaki ^a   Minshall, Richard D ^a   Le Breton, Guy C ^a   Rabito, Sara F ^a,b  

^a UNIVERSITY OF ILLINOIS   (United States)

^b Jr Hospital of Cook County   (United States)

Author keywords

angiotensin converting enzyme inhibitors; bradykinin; phorbol esters; phospholipases; signal transduction

Indexed keywords

1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 1H PYRROLE 2,5 DIONE; 15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; BRADYKININ; BRADYKININ B2 RECEPTOR; BRADYKININ B2 RECEPTOR ANTAGONIST; CALCIUM ION; CINNAMYL ANTHRANILATE; DEXAMETHASONE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ICATIBANT; INDOMETACIN; INOSITOL 1,4,5 TRISPHOSPHATE; KININASE; PHOSPHOLIPASE A2; PHOSPHOLIPASE C; PHOSPHOLIPASE C INHIBITOR; PROTEIN KINASE C; STAUROSPORINE; SULOTROBAN; THROMBOXANE A2; THROMBOXANE A2 RECEPTOR BLOCKING AGENT; THROMBOXANE RECEPTOR STIMULATING AGENT; CALCIUM; PHOSPHOLIPASE A;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CALCIUM CELL LEVEL; CALCIUM MOBILIZATION; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; ENZYME ACTIVATION; HEART MUSCLE CELL; HEART PROTECTION; HEART VENTRICLE WALL; KALLIKREIN KININ SYSTEM; NONHUMAN; PHOSPHOINOSITIDE METABOLISM; PRIORITY JOURNAL; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; ANIMAL; BIOSYNTHESIS; CYTOLOGY; DRUG EFFECT; HEART MUSCLE; HEART VENTRICLE; INTRACELLULAR MEMBRANE; METABOLISM; NEWBORN; PHYSIOLOGY; SPRAGUE DAWLEY RAT; TRANSPORT AT THE CELLULAR LEVEL;

ANIMALS; ANIMALS, NEWBORN; BIOLOGICAL TRANSPORT; BRADYKININ; CALCIUM; HEART VENTRICLES; INOSITOL 1,4,5-TRISPHOSPHATE; INTRACELLULAR MEMBRANES; MYOCARDIUM; PHOSPHOLIPASE C; PHOSPHOLIPASES A; PROTEIN KINASE C; RATS; RATS, SPRAGUE-DAWLEY; THROMBOXANE A2;

EID: 0029665584     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.28.3.444     Document Type: Article

References (36)

1. Captopril Multicenter Research Group. A placebo-controlled trial of captopril in refractory chronic congestive heart failure. J Am Coll Cardiol. 1983;2:755-763.
2. Pfeffer MA, Braunwald E, Moyé LA, on behalf of the SAVE investigators. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction: results of the survival and ventricular enlargement trial. N Engl J Med. 1992;327:669-677.
3. CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure. N Engl J Med. 1987;316:1429-1435.
4. Pfeffer MA, Pfeffer JM, Steinberg C, Finn P. Survival after an experimental myocardial infarction: beneficial effects of long term therapy with captopril. Circulation. 1985;72:406-412.
5. Sechi LA, Griffin CA, Grady EF, Kalinyak JE, Schambelan M. Characterization of angiotensin II receptor subtypes in rat heart. Circ Res. 1992;71:1482-1489.
6. Dostal DE, Baker KM. Angiotensin II stimulation of left ventricular hypertrophy in adult rat heart. Am J Hypertens. 1992;5:276-280.
7. Yang H, Erdös EG, Levin Y. A dipeptidyl carboxypeptidase that converts angiotensin and inactivates bradykinin. Biochim Biophys Acta. 1970;214:374-376.
8. Erdös EG. Angiotensin I-converting enzyme and the changes in our concepts through the years. Hypertension. 1990;16:363-370.
9. Linz W, Schölkens BA. Role of bradykinin in the cardiac effects of angiotensin-converting enzyme inhibitors. J Cardiovasc Pharmacol. 1992;20(suppl 9):S83-S90.
10. Noda K, Sasaguri M, Ideishi M, Ikeda M, Arakawa K. Role of locally formed angiotensin II and bradykinin in the reduction of myocardial infarct size in dogs. Cardiovasc Res. 1993;27:334-340.
11. Linz W, Wiemer G, Scholkens BA. Contribution of bradykinin to the cardiovascular effects of ramipril. J Cardiovasc Pharmacol. 1993;22(suppl 9):S1-S8.
12. Hartman JC, Hullinger TG, Wall TM, Shebuski RJ. Reduction of myocardial infarct size by ramiprilat is independent of angiotensin II synthesis inhibition. Ear J Pharmacol. 1993;234:229-236.
13. Minshall RD, Nakamura F, Becker RP, Rabito SF. Characterization of bradykinin receptors in adult myocardium and neonatal rat cardiomyocytes. Circ Res. 1995;76:773-780.
14. Berridge MJ. Inositol triphosphate and diacylglycerol: two interacting second messengers. Annu Rev Biochem. 1987;56:159-193.
15. Yang CM, Hsia H-P, Chou S-P, Ong R, Hsieh J-T, Luo S-F. Bradykinin-stimulated phosphoinositide metabolism in cultured canine tracheal smooth muscle cells. Br J Pharmacol. 1994;111:21-28.
16. Hepler JR, Earp HS, Harden TK. Long-term phorbol ester treatment down-regulates protein kinase C and sensitizes the phosphoinositide signaling pathway to hormone and growth factor stimulation. J Biol Chem. 1988;263:7610-7619.
17. 3 formation in cultured airway smooth muscle. Am J Physiol. 1989;257:L209-L216.
18. 2. Proc Natl Acad Sci U S A. 1987;84:6374-6378.
19. Silvka SR, Insel PA. Phorbol ester and neomycin dissociate bradykinin receptor-mediated arachidonic acid release and polyphosphoinositol hydrolysis in Madin-Darby canine kidney cells. J Biol Chem. 1988;263:14640-14647.
20. 2 and thromboxane prostanoid receptors. Am J Respir Crit Care Med. 1994;150:1012-1018.
21. Sukuma I, Gross SS, Levi R. Positive inotropic effect of the thromboxane analog U-46619 on guinea pig left atrium: mediation by specific receptors and association with increased phosphoinositide turnover. Can J Physiol Pharmacol. 1989;67:943-949.
22. Sadoshima J, Jahn L, Takahashi T, Kulik TJ, Izumo S. Molecular characterization of the stretch-induced adaptation of cultured cardiac cells. J Biol Chem. 1992;267:10551-10560.
23. 2 mobilizes calcium in human blood platelets. Am J Physiol. 1985;249:H1-H7.
24. Minshall RD, Yelamanchi VP, Djokovic A, Miletich DJ, Erdös EG, Rabito SF, Vogel SM. Importance of the sympathetic innervation in the positive inotropic effects of bradykinin and ramiprilat. Circ Res. 1994;74:441-447.
25. Bradford MM, A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248-254.
26. 2 receptor antagonist S-145 and related compounds, 3: conformation and activity of S-145 analogues. J Med Chem. 1991;34:1885-1891.
27. Uhlig S, Wollin L, Wendel A. Contributions of thromboxane and leukotrienes to PAF-induced impairment of lung function in the rat. J Appl Physiol. 1994;77:262-269.
28. Busse R, Fleming I. Kinin-mediated signal transduction in endothelial cells. In: Schölkens BA, Unger T, eds. ACE Inhibitors, Endothelial Function and Atherosclerosis. Sussex, UK: Media Medica Publications Ltd; 1993:1-18.
29. Lokuta AJ, Cooper C, Gaa ST, Wang HE, Rogers TB. Angiotensin II stimulates the release of phospholipid-derived second messengers through multiple receptor subtypes in heart cells. J Biol Chem. 1994;269:4832-4838.
30. Revtyak GE, Buja LM, Chien KR, Campbell WB. Reduced arachidonate metabolism in ATP-depleted myocardial cells occurs early in cell injury. Am J Physiol. 1990;259:H582-H591.
31. 2+ content of platelet internal stores. Biochem Biophys Res Commun. 1995;210:889-897.
32. 2 receptors. Br J Pharmacol. 1994;113:1167-1172.
33. Linz W, Wiemer G, Gohlke P, Unger T, Schölkens BA. Contribution of kinins to the cardiovascular actions of angiotensin-converting enzyme inhibitors. Pharmacol Rev. 1995;47:25-49.
34. Moss J, Hom BE, Hewlett EL, Tsai S-C, Adamik R, Halpern JL, Price SR, Manganiello VC. Mechanism of enhanced sensitivity to bradykinin in pertussis toxin-treated fibroblasts: toxin increases bradykinin-stimulated prostaglandin formation. Mol Pharmacol. 1988; 34:279-285.
35. Etscheid BG, Villereal ML. Coupling of bradykinin receptors to phospholipase C in cultured fibroblasts is mediated by a G-protein. J Cell Physiol. 1989;140:264-271.
36. Etscheid BG, Ko PH, Villereal ML. Regulation of bradykinin receptor level by cholera toxin, pertussis toxin and forskolin in cultured human fibroblasts. Br J Pharmacol. 1991;103:1347-1350.